Zantl N - Search Results

1

Amplification of epidermal growth factor receptor gene in renal cell carcinoma.

El-Hariry I, Powles T, Lau MR, Sternberg CN, Ravaud A, von der Maase H, Zantl N, Harper P, Rolland F, Audhuy B, Barthel F, Machiels JP, Patel P, Kreuser ED, Hawkins RE. El-Hariry I, et al. Among authors: zantl n. Eur J Cancer. 2010 Mar;46(5):859-62. doi: 10.1016/j.ejca.2010.01.011. Epub 2010 Feb 16. Eur J Cancer. 2010. PMID: 20167476 Clinical Trial.

2

Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.

Ravaud A, Hawkins R, Gardner JP, von der Maase H, Zantl N, Harper P, Rolland F, Audhuy B, Machiels JP, Pétavy F, Gore M, Schöffski P, El-Hariry I. Ravaud A, et al. Among authors: zantl n. J Clin Oncol. 2008 May 10;26(14):2285-91. doi: 10.1200/JCO.2007.14.5029. J Clin Oncol. 2008. PMID: 18467719 Clinical Trial.

3

Functional evaluation of the apoptosome in renal cell carcinoma.

Gerhard MC, Zantl N, Weirich G, Schliep S, Seiffert B, Häcker G. Gerhard MC, et al. Among authors: zantl n. Br J Cancer. 2003 Dec 1;89(11):2147-54. doi: 10.1038/sj.bjc.6601436. Br J Cancer. 2003. PMID: 14647151 Free PMC article.

4

Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1.

Zall H, Weber A, Besch R, Zantl N, Häcker G. Zall H, et al. Among authors: zantl n. Mol Cancer. 2010 Jun 24;9:164. doi: 10.1186/1476-4598-9-164. Mol Cancer. 2010. PMID: 20576107 Free PMC article.

5

Frequent loss of expression of the pro-apoptotic protein Bim in renal cell carcinoma: evidence for contribution to apoptosis resistance.

Zantl N, Weirich G, Zall H, Seiffert BM, Fischer SF, Kirschnek S, Hartmann C, Fritsch RM, Gillissen B, Daniel PT, Häcker G. Zantl N, et al. Oncogene. 2007 Oct 25;26(49):7038-48. doi: 10.1038/sj.onc.1210510. Epub 2007 May 7. Oncogene. 2007. PMID: 17486061

6

Multimodal tumor therapy in a 31-year-old pregnant woman with Wilms tumor.

Maurer T, Zorn C, Klein E, Weirich G, Beer AJ, Gschwend JE, Zantl N. Maurer T, et al. Among authors: zantl n. Urol Int. 2009;83(3):364-7. doi: 10.1159/000241685. Epub 2009 Oct 13. Urol Int. 2009. PMID: 19829043

7

Comparison of 16-MDCT and MRI for characterization of kidney lesions.

Beer AJ, Dobritz M, Zantl N, Weirich G, Stollfuss J, Rummeny EJ. Beer AJ, et al. Among authors: zantl n. AJR Am J Roentgenol. 2006 Jun;186(6):1639-50. doi: 10.2214/AJR.04.1545. AJR Am J Roentgenol. 2006. PMID: 16714654

8

Massive chemokine transcription in acute renal failure due to polymicrobial sepsis.

Maier S, Emmanuilidis K, Entleutner M, Zantl N, Werner M, Pfeffer K, Heidecke CD. Maier S, et al. Among authors: zantl n. Shock. 2000 Aug;14(2):187-92. doi: 10.1097/00024382-200014020-00019. Shock. 2000. PMID: 10947165

9

Impact of experimental peritonitis on bone marrow cell function.

Barthlen W, Zantl N, Pfeffer K, Heidecke CD, Holzmann B, Stadler J. Barthlen W, et al. Among authors: zantl n. Surgery. 1999 Jul;126(1):41-7. doi: 10.1067/msy.1999.99060. Surgery. 1999. PMID: 10418591

10

Positive effects of zoledronate on skeletal-related events in patients with renal cell cancer and bone metastases.

Tunn UW, Stenzl A, Schultze-Seemann W, Strauss A, Kindler M, Miller K, Wirth MP, Zantl N, Schulze M, May C, Ruebel A, Birkholz K, Gruenwald V. Tunn UW, et al. Among authors: zantl n. Can J Urol. 2012 Jun;19(3):6261-7. Can J Urol. 2012. PMID: 22704310 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters